Processa Pharmaceuticals, Inc.

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.
Frequently asked questions
To buy Processa Pharmaceuticals, Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Processa Pharmaceuticals, Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Processa Pharmaceuticals, Inc. is PCSA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Processa Pharmaceuticals, Inc. has its primary listing on NASDAQ (Small cap). You can trade Processa Pharmaceuticals, Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Processa Pharmaceuticals, Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Processa Pharmaceuticals, Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Processa Pharmaceuticals, Inc. or others.